Oral administration of non‐absorbable delayed release 6‐mercaptopurine is locally active in the gut, exerts a systemic immune effect and alleviates Crohn's disease with low rate of side effects: results of double blind Phase II clinical trial

Publisher： John Wiley & Sons Inc

E-ISSN： 1365-2249|181|2|362-372

ISSN： 0009-9104

Source： CLINICAL & EXPERIMENTAL IMMUNOLOGY, Vol.181, Iss.2, 2015-08, pp. : 362-372

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Possible therapeutic effect of carvacrol on asthmatic patients: A randomized, double blind, placebo‐controlled, Phase II clinical trial

By  

PHYTOTHERAPY RESEARCH, Vol. 32, Iss. 1, 2018-01 ,pp. : 151-159

John Wiley & Sons Inc

Access to resources Recommend Favorite

Effects of Oral Administration of Lactobacillus acidophilus L-92 on the Symptoms and Serum Cytokines of Atopic Dermatitis in Japanese Adults: A Double-Blind, Randomized, Clinical Trial

By  

International Archives of Allergy and Immunology, Vol. 165, Iss. 4, 2015-01 ,pp. : 247-254

Karger

Access to resources Recommend Favorite

Effects of rotigotine transdermal patch in patients with Parkinson's disease presenting with non‐motor symptoms – results of a double‐blind, randomized, placebo‐controlled trial

By  

EUROPEAN JOURNAL OF NEUROLOGY, Vol. 22, Iss. 10, 2015-10 ,pp. : 1400-1407

John Wiley & Sons Inc

Access to resources Recommend Favorite

Effects of rotigotine transdermal patch in patients with Parkinson's disease presenting with non‐motor symptoms – results of a double‐blind, randomized, placebo‐controlled trial

By  

EUROPEAN JOURNAL OF NEUROLOGY, Vol. 1351-5101, Iss. 10, 2015-10 ,pp. : 1400-1407

John Wiley & Sons Inc

Access to resources Recommend Favorite

Randomised clinical trial: vercirnon, an oral CCR9 antagonist, vs. placebo as induction therapy in active Crohn's disease

By  

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, Vol. 269-2813, Iss. 10, 2015-11 ,pp. : 1170-1181

John Wiley & Sons Inc

Access to resources Recommend Favorite